Sonim Technologies (SONM)
(Delayed Data from NSDQ)
$2.50 USD
0.00 (0.00%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.58 +0.08 (3.20%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
SONM 2.50 0.00(0.00%)
Will SONM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SONM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SONM
Analysts Estimate Sonim (SONM) to Report a Decline in Earnings: What to Look Out for
Itron (ITRI) Surpasses Q2 Earnings and Revenue Estimates
SONM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Synaptics (SYNA) Q3 Earnings and Revenues Beat Estimates
InterDigital (IDCC) Beats Q1 Earnings and Revenue Estimates
Sonim (SONM) Stock Drops Despite Market Gains: Important Facts to Note
Other News for SONM
Warning: SONM is at high risk of performing badly
SONM Stock Earnings: Sonim Technologies Misses EPS, Beats Revenue for Q2 2024
Warning: SONM is at high risk of performing badly
Looking Into Sonim Technologies's Recent Short Interest
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session